SDZ-MKT-077

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSDZ-MKT-077
Drug Alias NameSDZ-MKT-077FJ-776MKT-077
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock 70 kDa protein 1 inhibitors
TargetsHeat shock 70 kDa protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFujifilm GroupDana-Farber Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDana-Farber Cancer InstituteFujifilm GroupNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A